Published in J Biol Chem on June 07, 2001
Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity (2010) 2.82
Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction. Structure (2005) 1.70
T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 1.49
GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med (2009) 1.25
Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity (2009) 1.22
Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. Sci Signal (2011) 1.04
Phenotypic models of T cell activation. Nat Rev Immunol (2014) 0.94
A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes. Clin Vaccine Immunol (2010) 0.90
CD28: direct and critical receptor for superantigen toxins. Toxins (Basel) (2013) 0.86
Soluble T cell receptor Vβ domains engineered for high-affinity binding to staphylococcal or streptococcal superantigens. Toxins (Basel) (2014) 0.86
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
Assessing energetic contributions to binding from a disordered region in a protein-protein interaction . Biochemistry (2010) 0.82
The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity. PLoS One (2013) 0.81
High affinity of interaction between superantigen and T cell receptor Vbeta molecules induces a high level and prolonged expansion of superantigen-reactive CD4+ T cells. J Biol Chem (2010) 0.80
Staphylococcal enterotoxin H contrasts closely related enterotoxins in species reactivity. Immunology (2002) 0.79
The SCHOOL of nature: IV. Learning from viruses. Self Nonself (2010) 0.77
Characterization of the Staphylococcal enterotoxin A: Vβ receptor interaction using human receptor fragments engineered for high affinity. Protein Eng Des Sel (2013) 0.77
Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse. Clin Dev Immunol (2013) 0.76
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science (1987) 5.32
The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity (1998) 5.20
Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science (1986) 4.94
Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med (1994) 4.91
Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78
Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell (1986) 4.71
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature (1987) 3.63
Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature (1988) 3.63
Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) (2006) 3.40
Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature (1992) 3.36
Myeloma based expression system for production of large mammalian proteins. Trends Biotechnol (1991) 2.82
Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A (1989) 2.73
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
Immunological self, nonself discrimination. Science (1987) 2.59
Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc Natl Acad Sci U S A (1986) 2.42
Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 2.37
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med (1997) 2.33
Inherited immunoglobulin idiotypes of the mouse. Immunol Rev (1977) 2.29
Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A (1994) 2.18
Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature (1989) 2.17
Structure and function of the T-cell receptor: insights from X-ray crystallography. Immunol Today (1996) 2.02
Age of second-language acquisition and perception of speech in noise. J Speech Lang Hear Res (1997) 2.00
Structural analysis of peptides capable of binding to more than one Ia antigen. J Immunol (1989) 1.85
Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol (2000) 1.71
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature (1999) 1.69
Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. Tissue Antigens (2002) 1.68
Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol (2000) 1.68
The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure. Science (1986) 1.68
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
Capacity of intact proteins to bind to MHC class II molecules. J Immunol (1989) 1.63
I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif. J Immunol (1988) 1.61
Inheritance of antibody specificity V. Anti-2-phenyloxazolone in the mouse. J Exp Med (1978) 1.55
CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J (1994) 1.54
Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. J Biol Chem (1991) 1.54
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. J Immunol (1983) 1.52
SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens (2004) 1.52
Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.51
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia (1999) 1.45
Regulation and function of the CD3gamma DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. J Cell Biol (1997) 1.42
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia (2001) 1.40
A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry (1998) 1.39
Treatment of atopic dermatitis with mycophenolate mofetil. Br J Dermatol (2000) 1.39
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmol Suppl (1971) 1.37
Three-dimensional structure of an antigen-antibody complex at 6 A resolution. Nature (1985) 1.34
Molecular, cellular, and functional properties of bone marrow T lymphocyte progenitor clones. J Exp Med (1987) 1.33
Molecular basis of antigen mimicry by an anti-idiotope. Nature (1995) 1.32
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia (2013) 1.31
Using statistical decision theory to predict speech intelligibility. I. Model structure. J Acoust Soc Am (2001) 1.31
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia (2005) 1.31
Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur J Immunol (1996) 1.30
Surface expression of the beta T cell receptor (TCR) chain in the absence of other TCR or CD3 proteins on immature T cells. EMBO J (1991) 1.30
A new mouse TCR V gamma gene that shows remarkable evolutionary conservation. EMBO J (1987) 1.29
A mendelian idiotype is demonstrable in the heteroclitic anti-NP antibodies of the mouse. Eur J Immunol (1978) 1.29
Normal T cell development is possible without 'functional' gamma chain genes. EMBO J (1986) 1.29
Release from masking caused by envelope fluctuations. J Acoust Soc Am (1985) 1.29
Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization. J Biol Chem (1990) 1.29
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia (2012) 1.27
Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun (1999) 1.26
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia. Leukemia (2009) 1.25
MHC molecules protect T cell epitopes against proteolytic destruction. J Immunol (1992) 1.25
Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J Immunol (1992) 1.24
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc Natl Acad Sci U S A (1996) 1.24
Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations. Tissue Antigens (2001) 1.23
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci U S A (1999) 1.22
Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21
Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. Proc Natl Acad Sci U S A (1989) 1.20
T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med (1996) 1.19
Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur J Immunol (2001) 1.19
Frequency selectivity in normally-hearing and hearing-impaired observers. J Speech Hear Res (1980) 1.19
Thymocyte clones from 14-day mouse embryos. I. State of T cell receptor genes, surface markers, and growth requirements. J Exp Med (1987) 1.18
A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry (1996) 1.18
Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol (2000) 1.17
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16
Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. J Med Chem (1999) 1.14
Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. Eur J Biochem (1995) 1.14
Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Biochemistry (2000) 1.14
The structure of the T cell antigen receptor. Annu Rev Immunol (1996) 1.14
Oligopeptide antigens of the angiotensin lineage compete for presentation by paraformaldehyde-treated accessory cells to T cells. J Immunol (1986) 1.14
A novel approach for preparing anti-T cell receptor constant region antibodies. Eur J Immunol (1986) 1.13
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. EMBO J (1991) 1.13
MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet (1998) 1.10
Temporal integration in normal hearing, cochlear impairment, and impairment simulated by masking. J Acoust Soc Am (1988) 1.10
High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol (2001) 1.10
Effective attenuation of signals in noise under focused attention. J Acoust Soc Am (1991) 1.10
Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Immunol Rev (1998) 1.10
Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol (1989) 1.09